Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | UPMMY | MAIR |
|---|---|---|
| Price | $27.29 | $24.97 |
| Change today | ▼ 2.67% | ▼ 0.28% |
| Market cap | $14.79B | $14.78B |
| Return, 3 months | +5.1% | -28.3% |
| Return, year to date | -3.0% | – |
| Return, 1 year | +6.0% | – |
| P/E (TTM) | 20.1 | 89.5 |
| P/B | 1.3 | 4.0 |
| P/E percentile vs own 5y | – | 12th |
| Dividend yield | 6.31% | – |
| Revenue growth (YoY, latest qtr) | – | +20.9% |
| Net profit growth (YoY) | – | +128.9% |
| Gross margin | – | 38.9% |
| Operating margin | – | 15.1% |
| Net margin | – | 5.5% |
| Return on equity | – | 5.9% |
| Analyst target vs. price | – | +65.0% |
| Analyst buy share | – | 100% |
| RSI (14) | 36 | 45 |
| 30-day volatility | 24.6% | 51.6% |
| Max drawdown, 1 year | -21.3% | -46.5% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.